Clareon® PanOptix® Pro
Discover More Light
Utilization with Less
Light Scatter1,2*
*Compared to Clareon® PanOptix®, Based on bench and vision simulator studies.
Clareon® PanOptix® Pro
Discover More Light Utilization with Less Light Scatter1,2*
*Compared to Clareon® PanOptix®, Based on bench and vision simulator studies.
Everything You Love About Clareon® PanOptix®
Now With Less Light Scatter1-3**
Unprecedented 94% Light utilization4-10†
With ENLIGHTEN® NXT Optical Technology, PanOptix® Pro now offers:
- 50% less light scatter by harnessing 94% of total light energy1-3††
- The lowest light scatter of any trifocal IOL1-3,6,10‡,‡‡
- Uninterrupted light distribution across the full visual range1§
**PanOptix® has 88% light utilization (12% scatter light)/PanOptix® Pro 94% light utilization (6% scatter light).
†Compared to Clareon® PanOptix®.
††Compared to Clareon® PanOptix®. PanOptix® has 88% light utilization (12% scatter light)/PanOptix® Pro 94% light utilization (6% scatter light).
‡Based on bench and vision simulator studies.
‡‡Based on manufacturer reported values and respective methodology for Clareon PanOptix, Envista Envy, AT Elana, Gemetric and Rayner.
§Simulated photopic through-focus point spread function (light intensity [energy])—polychromatic.
Designed For Better Image Contrast1†§
Minimize Visual Disturbances
Built on the clinically proven visual disturbance profile of world-leading PanOptix®
Starburst
Only 2.6% of patients were bothered very much by starburst11§§ (n=220)
Halo
Only 1.4% of patients were bothered very much by halo11§§ (n=222)
Glare
Only 0.8% of patients were bothered very much by glare11§§ (n=221)
Outstanding Spectacle Independence
- True comfort at intermediate distance12-17¶
- High quality near vision up to the very close distance of 33 cm10¶¶
- Freedom from glasses even in low light18#,##
¶AT LISA^ tri 839MP^, PhysIOL FineVision^ and Envista^ Envy.
¶¶Based on data for AcrySof® IQ PanOptix® Trifocal IOL, AcrySof® IQ PanOptix® and Clareon® PanOptix® are optically equivalent.
#All-implanted analysis set.
##In response to the IOLSAT questionnaire question “In the past 7 days, how often did you need to wear eyeglasses to see”?
^Trademarks are the property of their respective owners.
Undeniable Patient Satisfaction
- PanOptix® is a trusted choice
- 99.2% of PanOptix® patients would have the same lens implanted again19||,¶¶
- 98.4% of PanOptix® patients would recommend the lens to a friend19¶¶,***
¶¶Based on data for AcrySof® IQ PanOptix® Trifocal IOL, AcrySof® IQ PanOptix® and Clareon® PanOptix® are optically equivalent.
||Response to the following question on IOLSAT questionnaire (Version 1.0, December 20, 2018) at 6 months post-op "Given your vision today, if you had to do it all over, would you have the same lenses implanted again?"; n=127
***Response to the following question on IOLSAT questionnaire at 6 months post-op "Given your vision today, would you recommend the lenses you had implanted to your family or friends?"; n=127.
Explore additional resources for Clareon® PanOptix® Pro IOLs
References:
1. Alcon data on file, 2025. REF-25218.
2. Alcon data on file, 2024. REF-25221.
3. Alcon data on file, 2015. REF-08546.
4. Alcon data on file, 2025. REF-25218.
5. Alcon data on file, 2015. REF-08546.
6. Muzychuk, A. Defocus Curve Performance of a Novel Hydrophobic Acrylic Trifocal Intraocular Lens: A prospective, Multicenter Canadian Study. ASCRS Annual Meeting, April 5-8, Boston.
7. Rayner Professional Website. https://rayner.com/en/iol/trifocal/rayone-trifocal/. Accessed September 2024.
8. Carones F. New Concept of Light Distribution for Bilateral Trifocal IOL Implantation. AAO. 2022;2022:53.
9. ZEISS AT LISA tri family. Supplement in Cataract and Refractive Surgery Today (Europe), September 2014.
10. Zeiss Cataract Insights: Laying the Myth or Reality; Digitalization enhances cataract surgery? Supplement in Ophthalmology Times, Europe; May 22, 2024; https://europe.ophthalmologytimes.com/zeiss-cataract-insight-series?page=1 Accessed September 2024.
11. Zhu D., Zhang J., et al. Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston.
12. Kohnen T, Lapid-Gortzak R, Ramamurthy D, et al. Clinical outcomes after bilateral implantation of a diffractive trifocal intraocular lens: A worldwide pooled analysis of prospective clinical investigations. Clinical Ophthalmology. 2023;Volume 17:155-163. doi:10.2147/ opth.s377234.
13. Charness N, Dijkstra K, Jastrzembski T, Weaver S, Champion M. Monitor viewing distance for younger and older workers. Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 2008;52(19):1614-1617. doi:10.1177/154193120805201965.
14. Government of Canada CC for OH and S. CCOHS: Office ergonomics. Canadian Centre for Occupational Health and Safety. April 25, 2023. Accessed May 9, 2023. https://www.ccohs.ca/oshanswers/ergonomics/office/.
15. Gundersen K, Potvin R. Trifocal intraocular lenses: A comparison of the visual performance and quality of vision provided by two different lens designs. Clinical Ophthalmology. 2017;Volume 11:1081-1087. doi:10.2147/opth.s136164.
16. Kohnen T, Titke C, Böhm M. Trifocal intraocular lens implantation to treat visual demands in various distances following lens removal.American Journal of Ophthalmology. 2016;161. doi:10.1016/j.ajo.2015.09.030.
17. Lwowski C, Pawlowicz K, Petermann K, et al. Visual and patient-reported factors leading to satisfaction after implantation of diffractive extended depth-of-focus and trifocal intraocular lenses. Journal of Cataract and Refractive Surgery. 2022;48(4):421-428. doi:10.1097/j.jcrs.0000000000000780.
18. Alcon data on file, 2018. REF-01475.
19. Clareon® PanOptix® Pro Trifocal Hydrophobic Acrylic IOL Model PXYWT0 2024 Directions for Use.
